1. The Board shall adopt regulations establishing a protocol for dispensing a self-administered hormonal contraceptive, as authorized by NRS 639.28078. Those regulations must include, without limitation:
(a) Requirements governing the information that must be included in a record concerning the dispensing of the self-administered hormonal contraceptive in addition to the information required by NRS 639.28078; and
(b) The amount of time that such a record must be maintained by the dispensing pharmacist or his or her employer.
2. The Board shall adopt regulations that prescribe:
(a) A risk assessment questionnaire that must be provided to a patient who requests a self-administered hormonal contraceptive pursuant to NRS 639.28078.
(b) The information that must be provided in writing to a patient to whom a self-administered hormonal contraceptive is dispensed pursuant to NRS 639.28078, which may include, without limitation, information concerning:
(1) The importance of obtaining recommended tests and screening from the patient’s attending provider or another qualified provider of health care who specializes in women’s health;
(2) The effectiveness of long-acting, reversible contraceptives as an alternative to self-administered hormonal contraceptives;
(3) When to seek emergency medical services as a result of administering a self-administered hormonal contraceptive; and
(4) The risk of contracting a sexually transmitted infection and ways to reduce that risk.
3. As used in this section:
(a) “Attending provider” means a provider of health care who provides or has provided care to the patient.
(b) “Provider of health care” has the meaning ascribed to it in NRS 629.031.